MedPage Today on MSN

FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients ...

US FDA investigates Takeda's blood disorder drug after pediatric death

The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda ...

FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder

FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for ...

Takeda Pharmaceuticals' Drug Adzynma Under FDA Investigation Related to Patient Death

Takeda Pharmaceuticals' drug Adzynma is being investigated by the U.S. Food and Drug Administration due to a death following treatment. The FDA said Friday it has received reports of neutralizing ...

Takeda blood disorder therapy Adzynma linked to patient death: FDA

Takeda Pharmaceutical (TAK) stock is in focus as the company's blood disease drug Adzynma is linked to a patient death, ...
Audacy on MSN

How to monitor, best prevent potential blood clots

Dr. James Hereth, critical care physician at Kaleida Health, says there are a couple of concerns that come to mind when hearing of a young athlete such as Buffalo Sabres forward Jiri Kulich dealing ...

One month of clot prevention after a stent was as effective as year-long course for AFib

New research found a simplified clot-preventing medication regimen following stent placement in adults with atrial fibrillation was just as safe and effective in preventing strokes, heart attack and ...